This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Verny E. Huertas, MD; Friedrich K. Port, MD; Victor V. Rozas, MD; John E. Niederhuber, MD

Arch Surg. 1976;111(2):162-166.

Abstract
• Pneumonia developed in 33 of 266 renal transplant recipients while they were receiving immunosuppressive therapy. Clinical factors were compared for patients with pneumonia and the control group of 220 transplant recipients without pneumonia. The diagnosis was usually established roentgenographically. Most cases of pneumonia were of bacterial origin and occurred within three months after transplantation. Pneumonia occurring during the first two postoperative weeks had no fatal outcomes. Patients with pneumonia occurring three to 12 weeks after transplantation had significantly greater leukopenia (P <.05) and more therapy for allograft rejection (P <.01) than the control group. Cases of fungal pneumonia developed later, were preceded by rejection, and had a poor prognosis. The mortality was 51.5% for all cases of pneumonia. Early diagnosis, prompt administration of specific antimicrobial agents, and immediate cessation of immunosuppressive therapy should improve the survival rate.

(Arch Surg 111:162-166, 1976)

Author Affiliations
From the Nephrology Division and departments of internal medicine and surgery, University of Michigan, Ann Arbor. Dr Huertas is a Fellow of the Kidney Foundation of Michigan.

Footnotes
Accepted for publication Oct 10, 1975.

Reprint requests to Nephrology Division, University of Michigan, 1405 E Ann St, Ann Arbor, MI 48104 (Dr Port).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary Infections: The Minnesota Randomized Prospective Trial of Cyclosporine vs Azathioprine-Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients
Hesse et al.
Arch Surg 1986;121:1056-1060.
ABSTRACT  

Head and Neck Infection After Renal Transplantation
Reyna et al.
JAMA 1982;247:3337-3339.
ABSTRACT  

Risk of Pneumococcal Infections in Renal Transplant Patients
Linnemann and First
JAMA 1979;241:2619-2621.
ABSTRACT